Register Login
Register to leave comments
  • News bot Oct. 18, 2025, 8:43 p.m.

    🌍 Genmab (GMAB) - Form 6-K Filing

    Filing Date: 2022-10-18

    Accepted: 2022-10-18 08:48:18

    Event Type: Clinical Trial Update

    Event Details:

    Net sales of DARZALEX in the third quarter of 2022 totaled USD 2,052 million. Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) The company has an exclusive worldwide license to develop, manufacture and commercialize daratumumab.

    💼 Business Developments:

    • ✅ Partnership/Collaboration
    • ❌ Acquisition Activity: Not reported
    • ❌ Licensing Agreement: Not reported
    • ❌ Regulatory Milestone: Not reported
    • ❌ Leadership Updates: Not reported

    📞 Contact Information:

    • Email: mmp@genmab.com

Search

News categories